The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Acerta Pharma; Motive Medical Intelligence
Stock and Other Ownership Interests - AstraZeneca
Patents, Royalties, Other Intellectual Property - Yale University (I)
Acalabrutinib alone or in combination with rituximab (R) in follicular lymphoma (FL).
 
Nathan Hale Fowler
Consulting or Advisory Role - Abbvie; Celgene; Merck; Roche
Research Funding - Abbvie; Celgene; Janssen; Roche
 
Morton Coleman
Stock and Other Ownership Interests - Kite, a Gilead company
Consulting or Advisory Role - Bayer; Celgene; Gilead Sciences
Speakers' Bureau - Bayer; Celgene; Gilead Sciences; Pharmacyclics
Research Funding - Bayer; Celgene; Gilead Sciences; Incyte; Merck
 
Don A. Stevens
Consulting or Advisory Role - Bayer
 
Sonali M. Smith
Consulting or Advisory Role - Abbvie/Genentech; Amgen; AstraZeneca; Celgene; Forty Seven; Genmab; Gilead Sciences; Juno Therapeutics; Kite, a Gilead company; NanoString Technologies; Pharmacyclics; Portola Pharmaceuticals; Roche; TG Therapeutics
 
Parameswaran Venugopal
Consulting or Advisory Role - Abbvie; Bayer
Travel, Accommodations, Expenses - Bayer
 
Peter Martin
Honoraria - Janssen
Consulting or Advisory Role - Acerta Pharma; Bayer; Celgene; Genentech/Roche; Gilead Sciences; Janssen; Kite, a Gilead company; Novartis; Pharmacyclics; Seagen; Verastem
Research Funding - Teva (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Janssen
 
Tycel Jovelle Phillips
Honoraria - Incyte; Pharmacyclics; Seagen
Consulting or Advisory Role - Incyte; Pharmacyclics; Seagen
 
Richy Agajanian
No Relationships to Disclose
 
Deborah Marie Stephens
No Relationships to Disclose
 
Raquel Izumi
Employment - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
Consulting or Advisory Role - Trigemina
Patents, Royalties, Other Intellectual Property - Patents pending for Acerta Pharma
 
Jean Cheung
Employment - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
Travel, Accommodations, Expenses - Acerta Pharma
 
J. Greg Slatter
Employment - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
 
Ming Yin
Employment - Acerta Pharma
Stock and Other Ownership Interests - AstraZeneca
 
Minoti Hiremath
No Relationships to Disclose
 
Naomi N. H. Hunder
Employment - Acerta Pharma; Seagen
Stock and Other Ownership Interests - AstraZeneca; Seagen
 
Beth Christian
Research Funding - Acerta Pharma; Bristol-Myers Squibb; Celgene; Genentech/Roche; Immunomedics; Janssen; Merck; Pharmacyclics; Seagen